Skip to main content

Table 3 CK elevation during telbivudine treatment

From: Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections

CK

Baseline

Week 12

Week 24

Week 36

Week 52

Week 72

Week 104

Grade 1, n

14

22

26

29

38

31

42

Grade 2, n

0

3

3

14

19

13

16

Grade 3, n

0

0

0

1

2

6

0

Grade 4, n

0

0

0

0

1

0

0

Total, n

14

25

29

44

60

50

58